Kelly Davis

Kelly Davis, PhD, serves as the Vice President of Research and Development for North America at Curium Pharma since February 2017, previously holding the position of Director of Portfolio Management. Prior to this role, Kelly worked at Mallinckrodt Pharmaceuticals from 2007 to February 2017, contributing as the R&D Engineering & Performance Excellence Leader, overseeing project integration for significant acquisitions, and managing a team of engineers in various development roles. Kelly holds a Master’s Degree in Biomedical Engineering from Tulane University and a Doctor of Philosophy in Engineering Management from Missouri University of Science and Technology, complemented by a Bachelor of Science in Biomedical Engineering from Tulane University.